Rationale:
Laser trabeculoplasty often provides long-lasting intraocular pressure reduction without the need for eye drops. The treatment is cost-effective and also eliminates issues related to patient compliance.
Reference:
- Gazzard et al 2019: Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet 2019 Apr 13;393(10180):1505-1516.L doi: 10.1016/S0140-6736(18)32213-X. Epub 2019 Mar 9.